Form D · Other Health Care
Pyxis Oncology, Inc.
Cambridge, MA · CIK 0001782223
Offering snapshot reported Mar 22, 2021 · SEC filing
- Reported sold
- $172M Offering amount: $172M
- Investors reported
- 38 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 5, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 22, 2021 | Initial | $172,499,998 | No comparison | 38 | SEC filing |
| Jul 12, 2019 | Initial | $21,999,999 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-393076
Source: Form D, filed Mar 22, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Crane | Executive |
| John Flavin | Director |
| Lucio Iannone | Director |
| Jak Knowles | Director |
| Gotham Makker | Director |
| Christopher O?Donnell | Director |
| Christian Schetter | Director |
| David Steinberg | Director |
| Lara Sullivan | Director, Executive |
| Geeta Vemuri | Director |
| Christoph Westphal | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
35 Cambridgepark Drive
Cambridge, MA, 02140
Cambridge, MA, 02140